Viewing nowRosuvastatin Calcium Tablets 20 Milligrams (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Handok Co., Ltd.

MFDS item code 201400388 · Approved 2014.01.28 · Insurance code 652104650
Improvement of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia who cannot be controlled with diet and exercise. It also helps patients with homozygous familial hypercholesterolemia along with diet or other therapies. This drug lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It is especially used in pediatric patients aged between 10 and 17 years with high LDL cholesterol levels despite dietary measures. It is also used as an adjunct in the treatment of primary dysbetalipoproteinemia. Additionally, it contributes to reducing the risks associated with cardiovascular diseases, such as stroke, myocardial infarction, and arterial revascularization. Therefore, this drug is effective in the prevention and treatment of dyslipidemia and cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients allergic to this drug, those with severe liver impairment, patients with muscle disorders, those with severe renal impairment, and women who are pregnant or nursing should not take this medication. Additionally, high-dose administration is prohibited in patients at high risk for muscle damage. This medication contains lactose, so caution is needed for patients with lactose intolerance. Before taking this medication, regular liver function tests and muscle-related tests should be conducted, and patients who consume significant amounts of alcohol or have a history of liver disease should exercise increased caution. Symptoms such as muscle pain, weakness, fatigue, and fever should be reported to healthcare professionals immediately. This drug may increase the risk of muscle damage when taken with certain other medications, so it is essential to consult healthcare professionals regarding concomitant drugs. Notably, dose adjustments or discontinuation may be required when used with fibrate drugs. Women who may become pregnant should use appropriate contraceptive methods while taking this medication, and it should not be used during pregnancy or if planning for pregnancy. In the case of overdose, there is no specific antidote, and treatment should be managed according to symptoms and liver function and muscle enzyme testing. When driving or operating machinery, caution is advised as dizziness may occur. Finally, if severe skin reactions such as rash, fever, or swelling of the face or neck occur during treatment, the medication should be discontinued immediately, and healthcare professionals should be consulted.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or humidity, and it is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Therefore, it is best to keep it away from direct sunlight and avoid placing it in locations that are too hot or too cold.
Pink round film-coated tablet
28 tablets (14 tablets/PTP packaging × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Handok Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.